Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update is a research paper published in Biomolecules (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: Z01 BC010891; ZIA BC010891
Intramural NIH HHS
Grant: ZIA BC010891
Intramural NIH HHS
Grant: Z01 BC010891
National Institutes of Health
Grant: 1ZIABC010891-15
Development of new antibody-based cancer therapies
FWCI
1.15
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
Additional file 1 of CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
Additional file 2 of CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
Additional file 2 of CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin